Indaptus Therapeutics (INDP) - Earnings growth in current year
Indaptus Therapeutics (INDP) is scaling its immune activation platforms to combat cancer, aiming to attract major partners. The annual variable EPS reflects the earnings per share trend, where the latest parameter stands at 0.00. While a team of top-tier scientists is developing bacterial therapies, the company faces intense pressure from industry behemoths and competing immunotherapy technologies.
Analytical breakdowns and data insights for company Indaptus Therapeutics (INDP)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Total Debt to Capital Coefficient Indaptus Therapeutics|INDP - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio indaptusrx.com|INDP - Company Aggregate Debts|Debt to Book Value Ratio Indaptus Corp|INDP - Company Long-Term Debts|Company Short-Term Debts Indaptus Therapeutics|Critical Liquidity Ratio indaptusrx.com
- earnings and market ratios statistics:
INDP - Net Income|Future Net Profit Indaptus Therapeutics|INDP - Price to Earnings Ratio|Forward P/E Multiple Indaptus Corp|INDP - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Indaptus Corp|INDP - Operating profit before deduction of amortization|Earnings per share for the trailing year Indaptus Therapeutics|INDP - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months indaptusrx.com|INDP - Earnings growth in current year|Expected earnings per share trend next year Indaptus Therapeutics
Fundamental valuation:Indaptus Therapeutics Inc
This metric measures the percentage change in earnings per share compared to the same period last year, reflecting the efficiency of capital generation. Professional investors utilize year-over-year EPS dynamics to assess an issuer's financial resilience to external shocks and market volatility. For Indaptus Therapeutics (INDP), this metric is secondary, as the development of cancer immunotherapy depends on scientific breakthroughs rather than economic cycles.
Direct competitors
Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|Grifols Group - Earnings growth in current year|Expected net earnings per share growth this year Adaptive Biotechnologies Inc. ADPT|Celldex Therapeutics (CLDX) - Earnings per share growth in current year|Earnings per share growth this year AUPH|BCRX (BioCryst Pharmaceuticals) - Earnings growth in current year|Earnings per share growth this year VERA (Vera Therapeutics Inc)|Earnings growth in current year DNTH|Earnings growth in current year Pharvaris Pharma (PHVS)|Earnings per share growth in current year AbCellera Biologics ABCL|TRML (tourmalinebio.com) - Earnings per share trend in current year|PGEN: Net earnings per share growth this year|Pharming Group NV - Net earnings per one share growth for the current year|NKTR (Nektar) - Net earnings per share growth this year|Upstream Pharma (UPB) - Earnings growth in current year|Earnings per share growth in current year Zenas Biopharma Inc|immunome.com (IMNM) - Expected net earnings per share growth this year|Net earnings per share growth this year GOSS (Gossamer Bio)|KALV (KalVista Pharma) - Earnings per share increase in current year|Septerna Corp - Net earnings per share growth this year|Net earnings per one share growth for the current year PVLA (Pieris Corp)|Savara Inc. - Earnings growth in current year|Earnings per share increase in current year RIGL (rigel.com)|ANAB: Earnings growth in current year|Earnings per share growth rate in current year Astria Therapeutics Inc (ATXS)|Earnings per share growth in current year enGene Bio|RAPT: Earnings per share increase in current year|Earnings growth in current year JBIO|Earnings growth in current year aclaristx.com (ACRS)|Earnings per share growth in current year Kyverna Therapeutics, Inc. KYTX|TLSA (Tiziana Life Sciences Ltd.) - Earnings per share trend in current year|Cabaletta Bio, Inc - Earnings growth in current year|Earnings per share growth rate in current year Ventyx Biosciences, Inc|THTX (Theratechnologies Inc.) - Net earnings per share growth this year|avalotx.com (AVTX) - Earnings growth in current year|Net earnings per share growth this year ELDN|AGEN (Agenus, Inc.) - Net earnings per one share growth for the current year|Earnings growth in current year CLYM|Expected net earnings per share growth this year Zura Bio Ltd|Earnings growth in current year ATYR (aTyr Pharma, Inc.)|ADAG - Net earnings per share growth this year|IMA - Earnings per share growth in current year|Expected net earnings per share growth this year Shattuck Labs, Inc. STTK|EQ: Earnings growth in current year|CNTB - Expected net earnings per share growth this year|Earnings per share growth in current year Immunic Therapeutics|Earnings per share growth this year ATRA (Atara Biotherapeutics Inc)|Earnings growth in current year IFRX|X4 Pharmaceuticals Inc. - Earnings per share growth this year|Earnings per share growth in current year Adicet Bio, Inc. ACET|CELU (Celularity Inc) - Earnings per share trend in current year|INMB - Earnings per share growth in current year|Earnings per share trend in current year BRNS|KZR: Earnings growth in current year|SAB Biotherapeutics Inc. - Earnings per share increase in current year|AKTX (Akari Therapeutics plc) - Earnings growth in current year|Earnings growth in current year Enlivex Therapeutics, Ltd.|Earnings per share growth in current year Q32 Bio Inc. (QTTB)|GOVX (geovax.com) - Earnings per share increase in current year|Earnings per share growth in current year Edesa Biotech EDSA|IBIO - Net earnings per share growth this year|Carisma Tx - Earnings growth in current year|XTLB - Earnings growth in current year|BOLT (boltbio.com) - Net earnings per share growth this year|HCW Biologics - Earnings per share increase in current year|APVO (Aptevo Therapeutics, Inc.) - Earnings growth in current year|AIM ImmunoTech, Inc. (AIM) - Expected net earnings per share growth this year|Earnings per share growth in current year Aditxt (ADTX)|Net earnings per share growth this year GRI Bio Corporation GRI|Earnings per share growth in current year XORTX Therapeutics Inc. XRTX|HIND - Net earnings per share growth this year|REVB: Net earnings per share growth this year|SCNI - Earnings growth in current year|calcimedica.com (CALI) - Earnings per share growth in current year|Earnings per share growth this year AFMD|ALLK (Allakos Inc) - Earnings growth in current year|Earnings per share growth rate in current year HOOKIPA HOOK|Earnings growth in current year IGMS|Expected net earnings per share growth this year iTeos Therapeutics Inc|Earnings per share growth in current year Ocean Bio OCEA|TCBP: Earnings per share growth this year|Third Harmonic Bio - Earnings growth in current year
